Ocl: Medgend

Ocl FDA Approved Drugs

CLEOCIN [Clindamycin Phosphate^{C₁₈H₃₄ClN₂O₈PS}]

100mg (vaginal suppository)

eq 1% base (topical swab)

eq 2% base (vaginal cream)

Pharmacia And Upjohn^{Aug 13, 1999}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

CLEOCIN PHOSPHATE [Clindamycin Phosphate^{C₁₈H₃₄ClN₂O₈PS}]

eq 150mg base/ml (injection injectable)

Pharmacia And Upjohn^{Approved Prior To Jan 1, 1982}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

CLEOCIN PHOSPHATE IN DEXTROSE 5% IN PLASTIC CONTAINER [Clindamycin Phosphate^{C₁₈H₃₄ClN₂O₈PS}]

eq 12mg base/ml (injection injectable)

eq 18mg base/ml (injection injectable)

eq 6mg base/ml (injection injectable)

Pharmacia And Upjohn^{Aug 30, 1989}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

CLEOCIN T [Clindamycin Phosphate^{C₁₈H₃₄ClN₂O₈PS}]

eq 1% base (topical solution)

Pharmacia And Upjohn^{Approved Prior To Jan 1, 1982}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

CLINDA-DERM [Clindamycin Phosphate^{C₁₈H₃₄ClN₂O₈PS}]

eq 1% base (topical solution)

Paddock Llc^{Sep 30, 1992}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

CLINDAGEL [Clindamycin Phosphate^{C₁₈H₃₄ClN₂O₈PS}]

eq 1% base (topical gel)

Precision Dermat^{Nov 27, 2000}

Topical treatment of acne vulgaris.

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

CLINDAMYCIN PHOSPHATE [Clindamycin Phosphate^{C₁₈H₃₄ClN₂O₈PS}]

1% (topical aerosol, foam)

eq 1% base (topical swab)

eq 150mg base/ml (injection injectable)

eq 2% base (vaginal cream)

Perrigo Uk Finco^{Mar 31, 2010}
Akorn^{Jun 17, 2010}
Fougera Pharms^{Feb 14, 2006}
Fougera Pharms Inc^{Jun 5, 1997}
G And W Labs Inc^{Sep 1, 1988}
Perrigo New York^{May 25, 2000}
Taro Pharm Inds^{Mar 31, 2004}
Teligent Pharma Inc^{Dec 30, 2016}
Vintage Pharms^{May 29, 2015}
Wockhardt^{Jul 15, 1997}
Alvogen Inc^{Jul 24, 1987}
Fresenius Kabi Usa^{Mar 29, 2007}
Sagent Pharms^{Sep 30, 2011}
West-ward Pharms Int^{Apr 25, 1988}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

CLINDAMYCIN PHOSPHATE IN 0.9% SODIUM CHLORIDE [Clindamycin Phosphate^{C₁₈H₃₄ClN₂O₈PS}]

eq 300mg base/50ml (eq 6mg base/ml) (iv (infusion) solution)

eq 600mg base/50ml (eq 12mg base/ml) (iv (infusion) solution)

eq 900mg base/50ml (eq 18mg base/ml) (iv (infusion) solution)

Baxter Hlthcare Corp^{Apr 20, 2017}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

CLINDAMYCIN PHOSPHATE IN 5% DEXTROSE IN PLASTIC CONTAINER [Clindamycin Phosphate^{C₁₈H₃₄ClN₂O₈PS}]

eq 12mg base/ml (injection injectable)

eq 18mg base/ml (injection injectable)

eq 6mg base/ml (injection injectable)

Akorn Inc^{Apr 4, 2013}
Celerity Pharms^{Jun 28, 2017}
Sandoz Inc^{May 31, 2012}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

CLINDAMYCIN PHOSPHATE IN DEXTROSE 5% [Clindamycin Phosphate^{C₁₈H₃₄ClN₂O₈PS}]

eq 900mg base/100ml (injection injectable)

Abraxis Pharm^{Dec 22, 1989}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

CLINDESSE [Clindamycin Phosphate^{C₁₈H₃₄ClN₂O₈PS}]

eq 2% base (vaginal cream)

Perrigo Pharma Intl^{Nov 30, 2004}

Method of treating bacterial vaginosis.

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

CLINDETS [Clindamycin Phosphate^{C₁₈H₃₄ClN₂O₈PS}]

eq 1% base (topical swab)

Perrigo Co^{Sep 30, 1996}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

ELIXOPHYLLIN [Theophylline^{C₇H₈N₄O₂H₂O}]

80mg/15ml (oral solution, elixir)

Nostrum Labs Inc^{Approved Prior To Jan 1, 1982}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

EVOCLIN [Clindamycin Phosphate^{C₁₈H₃₄ClN₂O₈PS}]

1% (topical aerosol, foam)

Mylan Pharms Inc^{Oct 22, 2004}

Treatment of acne vulgaris.

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

FASLODEX [Fulvestrant^{C₃₂H₄₇F₅O₃S}]

50mg/ml (intramuscular injectable)

Astrazeneca^{Apr 25, 2002}

Treatment of hormone receptor positive metastatic breast cancer in postmenopausal women with disease progression following antiestrogen therapy.
Treatment of hr-positive, human epidermal growth factor receptor 2 (her2)-negative advanced or metastatic breast cancer in combination with palbococlib in women with disease progression after endocrine therapy.

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

METOCLOPRAMIDE [Metoclopramide Hydrochloride^{C₁₄H₂₂ClN₃O₂ClHH₂O}]

eq 5mg base/ml (injection injectable)

Emcure Pharms Ltd^{Dec 20, 2013}

efficacy
0.0 (0)

side effects
0.0 (0)

danger
0.0 (0)

METOCLOPRAMIDE HYDROCHLORIDE [Metoclopramide Hydrochloride^{C₁₄H₂₂ClN₃O₂ClHH₂O}]

eq 10mg base (oral tablet)

eq 5mg base (oral tablet)

eq 5mg base/5ml (oral solution)

eq 5mg base/ml (injection injectable)

Impax Labs Inc^{Feb 3, 1988}
Ipca Labs Ltd^{Jun 12, 2008}
Novel Labs Inc^{Aug 15, 2014}
Par Pharm Inc^{Oct 17, 1985}
Teva^{Jul 29, 1985}
Vintage Pharms^{Aug 28, 2006}
Ani Pharms^{Jun 25, 1993}
Pharm Assoc^{May 28, 1991}
Vistapharm^{Jan 26, 2001}
Wockhardt^{Oct 31, 1997}
Fresenius Kabi Usa^{Apr 19, 2013}
Hospira^{Jan 17, 1991}
Teva Pharms Usa^{Nov 27, 1991}

efficacy
0.0 (0)

side effects
0.0 (0)

METOZOLV ODT [Metoclopramide Hydrochloride^{C₁₄H₂₂ClN₃O₂ClHH₂O}]

eq 5mg base (oral tablet, orally disintegrating)

Salix Pharms^{Sep 4, 2009}

REGLAN [Metoclopramide Hydrochloride^{C₁₄H₂₂ClN₃O₂ClHH₂O}]

eq 10mg base (oral tablet)

eq 5mg base (oral tablet)

Ani Pharms^{Approved Prior To Jan 1, 1982}

THEO-24 [Theophylline^{C₇H₈N₄O₂H₂O}]

100mg (oral capsule, extended release)

200mg (oral capsule, extended release)

300mg (oral capsule, extended release)

400mg (oral capsule, extended release)

Actient Pharms^{Aug 22, 1983}
Auxilium Pharms Llc^{Aug 22, 1983}
Auxilium Pharms Inc^{Feb 28, 1992}

THEOCHRON [Theophylline^{C₇H₈N₄O₂H₂O}]

100mg (oral tablet, extended release)

200mg (oral tablet, extended release)

Nostrum Pharms Llc^{Feb 21, 1985}

THEOPHYLLINE [Theophylline^{C₇H₈N₄O₂H₂O}]

100mg (oral tablet, extended release)

200mg (oral tablet, extended release)

300mg (oral tablet, extended release)

400mg (oral tablet, extended release)

450mg (oral tablet, extended release)

600mg (oral tablet, extended release)

80mg/15ml (oral solution, elixir)

Pliva^{Apr 30, 1990}
Alembic Pharms Ltd^{Oct 27, 2010}
Glenmark Generics^{Jul 13, 2010}
Mylan Ireland Ltd^{Apr 21, 2006}
Rhodes Pharms^{Sep 1, 1982}
Pharm Assoc^{Dec 16, 2016}
Silarx^{Apr 13, 2011}
Tris Pharma Inc^{Jun 15, 2012}

THEOPHYLLINE 0.04% AND DEXTROSE 5% IN PLASTIC CONTAINER [Theophylline^{C₇H₈N₄O₂H₂O}]

40mg/100ml (injection injectable)

B Braun^{Aug 14, 1992}

THEOPHYLLINE 0.08% AND DEXTROSE 5% IN PLASTIC CONTAINER [Theophylline^{C₇H₈N₄O₂H₂O}]

80mg/100ml (injection injectable)

B Braun^{Aug 14, 1992}

THEOPHYLLINE 0.16% AND DEXTROSE 5% IN PLASTIC CONTAINER [Theophylline^{C₇H₈N₄O₂H₂O}]

160mg/100ml (injection injectable)

B Braun^{Aug 14, 1992}

THEOPHYLLINE 0.32% AND DEXTROSE 5% IN PLASTIC CONTAINER [Theophylline^{C₇H₈N₄O₂H₂O}]

320mg/100ml (injection injectable)

B Braun^{Aug 14, 1992}

THEOPHYLLINE IN DEXTROSE 5% IN PLASTIC CONTAINER [Theophylline^{C₇H₈N₄O₂H₂O}]

160mg/100ml (injection injectable)

320mg/100ml (injection injectable)

40mg/100ml (injection injectable)

4mg/ml (injection injectable)

Hospira Inc^{Dec 14, 1984}

VENCLEXTA [Venetoclax^{C₄₅H₅₀ClN₇O₇S}]

100mg (oral tablet)

10mg (oral tablet)

50mg (oral tablet)

Abbvie Inc^{Apr 11, 2016}

Treatment of patients with chronic lymphocytic leukemia (cll) with 17p deletion, as detected by an fda approved test, who have received at least one prior therapy.

WARNING: Consult a licensed physician in the appropriate field for medical treatment and drug prescription. Do not self medicate.

WARNING: All medicines, drugs, plants, chemicals or medicial precedures below are for historical reference only. Many of these treatments are now known to be harmful and possibly fatal. Do not consume any plant, chemical, drug or otherwise without first consulting a licensed physician that practices medine in the appropriate field.

Felter's Materia Medica on Ocl

GELATINUM
Gelatin. A purified glue prepared by boiling gelatinous animal tissues in water and purifying, evaporating and drying the product. Description.A... / ...nges, wafers, suppositories, court plasters, and as a coating for pills. Its intravenous or hypodermoclytic use (of about 3 ounces of a 1 per cent sterile solution) to increase blood coagulation in a... / ...to its freedom from the formation of indol it has been advised as a part of the diet in intestinal putrefaction showing marked indicanuria.¹

GLUCOSUM
Glucose, Liquid Glucose, Syrupy Glucose. A syrupy liquid, composed chiefly of dextrose (dextro-glucose) and dextrin. It is obtained by the... / ... general anesthetics. Glucose, in 6 to 10 per cent solutions, has proved serviceable, given by enteroclysis, in dropsical effusions, provided the kidneys are not badly damaged, and in uremic eclampsia...¹

References

1) Felter, Harvey Wickes, 1922, The Eclectic Materia Medica, Pharmacology and Therapeutics, Cincinnati, Ohio.

Ledgend of Medicine

MODERN MEDICINES

HOME REMEDIES

RANDOM DRUGS

RANDOM AILMENTS

Ocl FDA Approved Drugs

Felter's Materia Medica on Ocl

References